Resultado de búsqueda
Hace 5 días · Leveraging mid-sagittal and para-sagittal brain image viewpoints from the Alzheimer’s disease neuroimaging initiative (ADNI) dataset, our framework demonstrated exceptional performance.
Hace 4 días · GALVESTON, Texas (KTRK) -- Something as simple as a puff from a nasal spray could be the Alzheimer's breakthrough millions have been waiting for. Alzheimer's and dementia disease can be a...
Hace 5 días · 1 INTRODUCTION. As the experimental therapeutic landscape for Alzheimer disease (AD) expanded in the early 2000s to incorporate putative disease-modifying therapies, 1 Neil Buckholtz, PhD, Chief of the Dementias of Aging Branch of the Division of Neuroscience at the National Institute of Aging (NIA), envisioned a major effort to collect data and samples to establish a brain imaging, biomarker ...
Hace 5 días · Tau pathology is a common denominator for neurodegenerative diseases such as Alzheimer’s disease or frontotemporal dementia, but selectively targeting toxic tau remains a challenge. Here, Gaikwad et al. developed a conformation-specific antibody for tau and demonstrated selective targeting of toxic tau aggregates in patient-derived tissue and tau oligomers in vitro.
Hace 4 días · Alzheimer’s disease can rob us of our memories, our independence and our lives, but a global effort is inspiring new hope. With careful reporting and expert-written commentary, this...
Hace 5 días · The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's...
Hace 4 días · Ciencia. La FDA aprobó un nuevo fármaco para el Alzheimer: cuáles son los otros tratamientos alternativos. Este martes se conoció la aprobación de donanemab para pacientes en estadio temprano de...
